Keyphrases
High Incidence
100%
Lymphoma
100%
Retrospective Analysis
100%
Methotrexate
100%
Renal Toxicity
100%
High-dose Methotrexate (HD-MTX)
33%
Hematological Malignancies
16%
Progression-free Survival
16%
Overall Survival
16%
Kidney Function
16%
Male Sex
16%
Length of Hospital Stay
16%
Old Age
16%
Proton Pump Inhibitors
16%
Sarcoma
16%
Renal Insufficiency
16%
Creatinine Clearance
16%
Baseline Creatinine
16%
Osteosarcoma
16%
Reported Incidence
16%
Methotrexate Clearance
16%
Pharmacology, Toxicology and Pharmaceutical Science
Methotrexate
100%
Nephrotoxicity
100%
Progression Free Survival
16%
Hematologic Malignancy
16%
Overall Survival
16%
Creatinine
16%
Elimination
16%
Retrospective Study
16%
Osteosarcoma
16%
Proton Pump Inhibitor
16%
Severe Renal Impairment
16%
Connective Tissue Cancer
16%